30 closest matches · ranked by relevance
Air Pollution
Primary: Concentrations of M1 and M2 Macrophages in the Sputum 24 Hours After Exposure. — 6.823; 1.367 ratio of M2 to M1 macrophages
Cardiometabolic Health
Primary: Systolic Blood Pressure — 127.0; 126.5 mm Hg — p=0.588
Attention Impaired · Risk-Taking · Risk Behavior
Primary: Response Speed Consistency Throughout the Attention Network Task-Flanker Task (Post ANT) — 161.3; 160.2 ms — p=0.52
Asthma
Primary: Spirometry, Percentage Change in FEV1 From Baseline — -1.0; -4.8; -2.2; -7.4 percentage change in FEV1 from baseline — p=<0.05
Asthma
Primary: PM2.5 Concentration (ug/m^3) — 18.95; 32.73 ug/m^3
Oxidative Stress · Inflammation · Blood Pressure
Primary: Biomarkers of Antioxidant Activity-Total Antioxidant Capacity (TAC) and Superoxide Dismutase (SOD) — 6.09; 5.80; 364.34; 356.59 U/ml
Chronic Obstructive Pulmonary Disease
Primary: Mean Change in St. George Respiratory Questionnaire — -12.5; -0.45 score on a scale
Vehicular Environment
Primary: Collect Preliminary Data on In-vehicle Excess Particulate Matter (PM) Exposure
Air Pollution
Primary: Systolic Blood Pressure (SBP) — 122.3; 120.83; 119.9 mmHg
Inflammation · Coagulation · Blood Pressure
Primary: Circulating Biomarkers — 926.3; 913.1; 1122.2; 1108.2 ng/ml
Pollution; Exposure · Health Behavior
Primary: Adoption of Protective Behaviour at 4 Weeks — 3.67; 4.25; 4.29; 3.65 units on a scale 1-9 — p=.964
COPD, Chronic Obstructive Pulmonary Disease
Primary: Change in Quality of Life -St. George's Respiratory Questionnaire (SGRQ) — -2.9; 1.5 score on a scale — p=0.025
Asthma · Asthma in Children
Primary: Number of Participants With at Least One Moderate or Severe Asthma Exacerbation Over Time — 5; 4; 13; 12 Participants — p=0.32
Blood Pressure
Primary: Changes of Serum Cortisol Levels — 0.012835; 0.016206 relative intensity — p=<0.05
Ozone Exposure During Rest and Exercise
Primary: Time-to-exhaustion on Maximal Cycling Bout — 209; 235 seconds — p=0.092
Asthma · Environmental Exposure · Home Environment Related Disease
Primary: Episodes Per Day — 2.22 Episodes per day
Autonomic Nervous System Imbalance · Blood Pressure · Inflammation
Primary: Heart Rate Variability-LF Power,HF Power,VLF Power — 899.4; 838.5; 519.7; 416.6 ms^2 — p=<0.05
Cardiovascular Diseases
Primary: Percent Change in Circulating Concentration of Tumor Necrosis Factor Alpha (TNFα) — -1.03; 2 percent change
Environmental Carcinogenesis
Primary: Sulforaphane Bioavailability Measured in Sequential 12-Hour Urine Samples — 24.8; 11.0; 4.3 micromoles/24 hours — p=<0.001
Asthma
Primary: Asthma Symptoms — 1.5; 2.9; 1; 0.4 Days
Asthma and/or Exercise Induced Bronchoconstriction · Ozone Air Pollution
Primary: Measured Before and 30 Minutes After Exercise in Each 1 Day Condition — 6.98; 5.96; -1.38; -.35 litres
Allergic Airway Disease
Primary: Total Nasal Cell Count in Response to DEP Challenge at 0, 6 and 24 hr With or Without BSE Intervention — 4.44; 4.50; 4.73; 4.70 log cells/mL — p=<0.001
Asthma
Primary: Maximum Symptom Days/14 Days — 2.7 days
Air Pollution Toxicity
Primary: Endothelial Progenitor Cells — 0.0025; 0.0027 # cells per CD41 minus cells
Tobacco Smoke Pollution
Primary: Air Nicotine Levels — 1.17; 0.58; 0.71; 0.51 mg/m^3
Lower Tract Respiratory Infection
Primary: Number of Participants With at Least One LRTI During Follow-up Period — 16; 20; 17; 138 Participants — p=0.68
Respiratory; Disorder, Functional, Impaired · Respiratory Infection Other
Primary: Post-intervention FEV1 — 1.9; 2.1; 2.0 liters — p=0.10
Mild Asthma
Primary: Post Ozone Change in Lung Function (FEV1) Between Subjects With GSTM1 Null Genotype Compared to GSTM1 Sufficient Subjects — 85; 79 percentage of FEV1 predicted
Inflammation · Sleep Deprivation · Circadian Rhythm Sleep Disorder, Shift Work Type
Primary: Blood Inflammation — 0.69; 0.79; 2.33; 1.63 pg/mL — p=<0.05
Airway Inflammation
Primary: Change From Baseline to 4 Hours in Sputum Percent Neutrophils — -2.62; 5.45 percent neutrophils — p=0.24